Fatty acid control of growth of human cervical and endometrial cancer cells. by Gleeson, R. P. et al.
Br. J. Cancer (1990), 61, 500-503
© Macmillan Press
Fatty acid control of growth of human cervical and endometrial cancer
cells
R.P. Gleeson', M. Ayub', J.T. Wright3, C.B. Wood2, N.A. Habib2, W.P. Soutter',
M.H.F. Sullivan' & J.O. White'
'Institute ofObstetrics and Gynaecology and 2Department ofSurgery, Royal Postgraduate Medical School, Hammersmith
Hospital, Du Cane Road, London W12 OHS, UK; and 3St Peter's Hospital, Guildford Road, Chertsey, Surrey KT16 OPZ, UK.
Summary Stearic acid and iodo-stearic acid inhibited cell growth in a cervical cancer cell line (HOG-1) in a
dose-related manner, with a half maximal effect at 50 JAM stearic acid. Addition of oleic acid abrogated the
effect of stearic acid. EGF-stimulated DNA synthesis and growth of HOG-1 cells was inhibited in the presence
of stearic acid without any apparent effect on EGF receptor number or affinity.
Many reports have demonstrated effects of fatty acids on cell
growth, showing growth stimulation in normal and neoplas-
tic cells (Wicha et al., 1979), growth inhibition without toxic
effects (Williams et al., 1974) and cytocidal effects (Siegel et
al., 1987). In general, saturated fatty acids (SFA) inhibit cell
growth (Doi et al., 1978), whereas unsaturated fatty acids
(USFA) stimulate growth (Wicha et al., 1979).
These effects may be explained by the alteration in func-
tional properties of cell membranes caused by changing their
fatty acid content (Spector & Burns, 1987). The function of
membrane proteins can be modified by the fluidity or micro-
viscosity of surrounding lipids, which may effect the confor-
mation and availability of membrane receptors (Shinitzky,
1984). Mobility within the plane of the cell membrane is
necessary for the activation of the epidermal growth factor
(EGF) receptor (Schlessinger, 1988), but there is no reported
work on the possible effects of fatty acid modulation of cell
membranes on EGF receptor function.
Stearic acid (SA) has been shown to inhibit growth of
normal and neoplastic rat mammary epithelial cells (Wicha et
al., 1979). As effects of fatty acids on neoplasic of the uterine
cervix have not been investigated, this work examines the
effect of stearic acid (SA) and 9 (10)-iodostearic acid (ISA),
which may strongly influence membrane fluidity (Apostolov,
1980), on a human cervical cancer cell line. Fatty acid mem-
brane modulation may affect the characteristics of receptor
proteins and, as the importance of EGF and its receptor in
the growth of gynaecological tumours has been suggested by
Cowley et al. (1984), Kudlow et al. (1986), Sainsbury et al.
(1987), Singletary et al. (1987) and Wu et al. (1981), we
therefore also investigated the effect of SA on EGF-
stimulated growth and receptor characteristics in HOG-1
cells.
Materials and methods
Maintenance ofcells in culture
HOG-1 cells were maintained in Dulbecco's Modified Eagle
Medium (DMEM) plus 10% heat inactivated fetal calf serum
(FCS) in 5% CO2 at 37°C. Gentamicin (640 1tg per 100 ml)
and glutamine (29.2 mg per 100 ml) were added to the
medium. As a preliminary step to each experiment, cells were
pre-incubated in DMEM containing 10% delipidised fetal
calf serum (DLS) for three days. DLS was prepared by
adding 50 ml of FCS to 500 ml of 1:1 ethanol:acetone. This
was stirred for 4 h and filtered through Watman no. 1 paper
with cold ether. The precipitate was dried, reconstituted in
deionised water, and the resulting serum was filter sterilised.
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Growth ofHOG-I cells in serum-free defined medium
Some experiments were conducted in serum-free chemically
defined medium to preclude the possible interaction of SA
with unspecified serum growth components. In these
experiments cells were plated in medium containing serum
and allowed to adhere overnight before changing to DME/
F12 supplemented with insulin (6.24 ILg ml-') transferrin
(6.25 sgml1'), selenium (6.25 ,sgml-'), bovine serum
albumin (BSA) (1.25 mg ml-') and linoleic acid
(5.35 sg ml1'). SA was prepared in ethanol as detailed
below, and this was added directly to the medium.
Treatment ofcells
Six (17.3 ml) or 12 (7.5 ml) multi-well plates were used, and
cells were seeded in DMEM/DLS at concentrations of
20-30 x 103 per well (12-well plates) or 100-300 x 103 per
well (six-well plates). After cell attachment the medium was
removed and replaced by medium containing the appropriate
additive. SA, ISA and oleic acid (OA) were supplied by
Sigma Chemical Company and were stored at 4°C. Fresh
solutions were prepared for each experiment. ISA and OA
were heated to 37°C before aliquoting as they are not liquid
at 4°C. All substances were dissolved in ethanol which was
then added to DLS to achieve the indicated concentration
and a final ethanol concentration of not greater than 0.1 % in
medium. For experiments using serum-free medium, SA was
dissolved in ethanol as usual, and this was added directly to
the medium. The same concentration of ethanol was added
to control media. Mouse EGF (Sigma) was stored at - 70°C.
This was reconstituted in phosphate buffered saline (PBS)
and added at a concentration of 20 ngml' of medium.
Measurement ofcell responses
The effects of each treatment on growth were determined by
measurement of cell numbers and DNA synthesis by 3H-
thymidine incorporation (0.5 ltCi methyl thymidine ml -'
medium; s.a. 40-60 Ci nmol-') into TCA-precipitable
material for the final 6 h of the experiment. Cell counts were
conducted in quadruplicate using a haemocytometer, count-
ing a minimum of 200 cells and assessing viability at each
time point using Trypan blue. NADH exclusion was also
used to assess cell viability (Aldred & Cooke, 1983).
To allow pooling of data, cell counts were expressed as a
percentage of the day 0 count. The resulting distribution of
data was tested for normality (Royston, 1983) and paired t
tests were used to compare results.
Measurement ofEGF receptor concentration and affinity
'25I-EGF was prepared by the lactoperoxidase method using
sodium iodide (Amersham) and mouse EGF (Sigma) to a
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final specific activity of approximately 120 jiCi jig -' (59%
incorporation). The iodinated EGF was desalted on a G-25
column. Cells were grown in six-well plates, and after incuba-
tion of the treated cells with SA (75 jiM) for 3 days, the
medium was removed and the cells washed three times with
1 ml DMEM containing 0.1% BSA. They were then
incubated for 1 h at 25°C with '25I-EFG (0.5 nM) in a total
volume of I ml and a range of concentrations of cold EGF
(0.018-5.0 nM) as competitor. Triplicate samples were
prepared. Non-specific binding was determined in the
presence of 100-fold excess of cold EGF. The medium was
removed after incubation and the cells washed three times
with I ml ice-cold DMEM containing 0.1% BSA. The cells
were solubilised in I ml 0.5 N NaOH, the radioactivity deter-
mined and analysed by the method of Scatchard (1949).
Results
Cell growth
Both SA and ISA significantly inhibited cell growth of HOG-
1 cells after 48 h in culture (P<0.005 for days 2, 3 and 4)
(Figure 1). There was no difference between the inhibition
seen with SA and ISA, both inhibited growth by 30-35% at
48 h. The growth inhibition was dose-dependent in the range
of 12.5-100 jiM (Figure 2). At 125 jiM SA, cell death occur-
red. Differences in growth rates assessed by cell numbers
were confirmed by 3H-thymidine incorporation assays; cont-
rol 42,153 ± 501 c.p.m.; SA (75 j M) 25,166 ± 359 c.p.m. on
day 2 (n=6, P<0.05).
The lower cell number at each time point in the SA-treated
group was not due to cytocidal effect. This was treated by
plating out cells and, after adding SA in the usual manner,
performing cell counts at 30 min, 2, 4 and 10 h. There was no
difference in cell counts (n = 3) between control and treated
cells in this time period. Trypan blue testing (at each time-
point cells were counted) showed no differences between
control and treated cells (data not shown).
In serum-free medium the inhibition of growth was less
marked than in DMEM/DLS, but by 72 h 23% growth
inhibition was seen: control cell no. = 307% of day 0 count
(s.d. 19%); SA treated cell no. = 273% of day 0 count (s.d.
10%); n = 3; P = 0.02.
SA in desaturated oleic acid, which contains a double bond
at the C9-C10 position. However, the growth inhibitory effect
is not mediated by OA, as the inhibitory effect of 75 tM SA
on HOG-I cells is abrogated by OA 30 jiM at 48 h (Figure
3).
The effect of SA on HOG-I cells is reversible. After
achieving 30% growth inhibition with SA (75 jM) after 48 h
in the usual manner, control and treated cells were harvested,
counted and tested for viability with Trypan blue and re-
suspended in DMEM + 10% FCS. Equal numbers of control
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Figure 1 Inhibition of growth of HOG-I cells by SA (1 ) and
ISA ( M ) (75 gM). Units are % of day 0 cell number per well;
(range day 0: 15-200 x 103 cells per well). Error bars are stan-
dard deviations in all figures. Significant inhibition at days 2, 3, 4
or both SA and ISA; n = 5; P<0.005 each time. =, control.
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Figure 2 Dose-response of HOG-I cells to SA (WJ) and ISA
( M ) at 48 h. Units are as in Figure 1. Significant growth
inhibition at 50 jiM SA (P = 0.01) and 50 jAM ISA (P = 0.009);
n = 6.
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Figure 3 Abrogation of inhibitory effect of SA (75 1AM) by OA
(30 1AM) at 48 h. Units are as in Figure 1. Range of day 0 cell
numbers: 20-30 x 103 per well; n = 4. Significant difference
between SA and SA + OA treatment; P = 0.015.
and previously SA-treatd cells were re-seeded into separate
50 ml flasks. Successive flasks were harvested and counted 24,
48 and 72 h following re-seeding, showing logarithmic growth
and no difference in cell numbers between control cells and
those which had been previously growth-inhibited by SA
(75 jM) (Figure 4). Growth inhibition without fall in
viability was also seen in an endometrial carcinoma cell line
(Ishikawa). There was 23% growth inhibition after 48 h in
the treated cells compared with control: control cell
no. = 255% of day 0 count (s.d. 28%), SA treated cell
no. = 197% of day 0 count (s.d. 23%); n = 3; P = 0.018.
Inhibition ofresponse to EGF
HOG-I cells contain membrane EGF receptors, and treat-
ment with EGF (20 ng ml-') for 3 days resulted in a 48%
increase in cell numbers, and 27% increase in 3H thymidine
incorporation. However, the stimulatory effect of EGF was
not seen when cells were treated with 75 jiM SA (P = 0.02;
n = 3; Figure 5). The presence of SA did not inhibit the
binding of iodinated EGF added to growth medium (data
not shown) therefore excluding the possibility of decreased
availability of hormone. There was no difference in EGF
receptor concentration per cell between control and treated
cells (control, 47.3 fmol per million cells; treated, 43.1 fmol
per million cells). Scatchard analysis showed no difference in
EGF receptor affinity between control cells and those to
which SA had been added (Kd control 3.41 nM; treated
5 2.82 nM; Figure 6).
Discussion
The fatty acid content of cell membranes may be altered by
changes in the composition of the growth medium, the extent
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Figure 4 Reversibility of effect of SA and ISA (75 JM). Units
are as in Figure 1. Range day 0: 0.75-1.05 x 106 cells per flask.
No difference in cell numbers 24, 48 and 72 after removal of SA;
n = 3. M, control; , SA treated.
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Figure 5 Lack of response to EGF in HOG-1 cell numbers after
72 h when cells treated with SA 75 gM. Units are as in Figure 1.
Range of day 0 cell numbers = 16-35 x 10' cells per well.
Significant difference between EGF-treated and EGF + SA
treated cells; P = 0.02.
of enrichment of a particular FA being dependent on the
amount of supplement added (Yorek et al., 1984). Such
alterations lead to changes in the physical and functional
properties of the membrane such as altered fluidity (Chap-
man & Quinn, 1976), transport (Spector & Burns, 1987) and
enyzme and receptor protein activity (Sandermann, 1978;
Shinitzky, 1984). Changes in receptor protein activity may be
due to conformational changes induced by alteration in sur-
rounding lipid (Shinitzky, 1984).
Stearic acid (an 18-carbon SFA) effectively inhibits
phytohaemagglutinin (PHA)-induced transformation of
lymphocytes (Mertin & Hughes, 1975) and '4C-uridine
uptake by PHA-stimulated lymphocytes (Weyman et al.,
1977). Our results show that SA is capable of reversibly
inhibiting cell growth in a cervical squamous carcinoma cell
line. Growth is inhibited by 30-35% after 48 h in DMEM/
DLS; and by 22% in serum-free medium after 72 h.
An endometrial cancer cell line shows 23% growth inhibi-
tion after 72 h. The finding that OA negates the effect of SA
agrees with the results of Weyman et al. (1975) concerning
uridine uptake by lymphocytes and Doi et al. (1978), who
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Figure 6 Scatchard analysis of EGF binding to HOG-1 cells.
Comparison of control (0) and SA (75 gM) treated (@) cells,
showing no difference in Kd (3.41 nm control; 2.82 nM SA-treated)
or receptor number (47.3 fmol per 106 cells control; 43.1 fmol per
106 cells SA treated). Correlation coefficient (r) control and
treated = - 0.89; P<0.01.
measured growth of mouse LM cells.
Both high and low affinity binding sites for EGF have
been reported in many cell lines (King & Cuatrecasas, 1982;
Kawamoto et al., 1983). Cell lines expressing only a single
class of EGF receptor are also described (Mummery et al.,
1983; Fabbro et al., 1986). Using EGF concentrations rang-
ing from 0.018 to 5.0 nm, there was no evidence of two
receptor affinities in the HOG-I cell line. Under the con-
ditions of the assay (25°C for I h) greater than 90% of
cell-associated radioactivity was removed by acid washing,
consisteht with other reports (Imai et al., 1982; Fabbro et al.,
1986), suggesting that analysis of the binding data is not
complicated by internalisation. The inhibition of EGF-
stimulated growth in the presence of SA cannot be explained
by availability of growth factor or changes in receptor
number or affinity. Interference with signal transduction dis-
tal to ligand binding, for example an effect on receptor
clustering (Schlessinger, 1988) and/or protein tyrosine kinase
activity (Northwood & Davis, 1989) may explain the
observed effects of SA.
Although previous work has shown effects of lipid-
modulated changes in membrane fluidity on receptor proteins
(Shinitzky, 1984; Spector & Burns, 1987; Ginsberg et al.,
1981) there have been few reports of FA effects on the EGF
receptor. Gladhaug et al. (1988) demonstrated that the 4-
carbon butyrate increases EGF receptor binding in rat
hepatocytes, and affects receptor status and cell morphology.
It is possible that modulation of membrane viscosity sur-
rounding the EGF receptor leads to a conformational change
in the receptor, possibly inhibiting dimer/oligomer formation.
EGF mediates pleotropic effects on cells, including the sit-
mulation of mitogenesis (Gullick & Waterfield, 1987), and
has a demonstrably important role in gynaecological malig-
nancy. In this context, there could possibly be a role for
saturated fatty acids in the management of malignancy, pos-
sibly as an adjunctive treatment.
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